Neurohatic pain costs according it's etiology the Spanish Pain Units;Costes del dolor neuropático según etiología en las Unidades del Dolor en España

Revista de la Sociedad Espanola del Dolor

Volumn 14, Issue 6, 2007, Pages 404-415

  Rodriguez M J ^a   Garcia A J ^b  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b UNIVERSITY OF MÁLAGA   (Spain)

Author keywords

Aetiology; Costs; Neuropathic pain; Pain clinics; Spain

Indexed keywords

ADULT; ARTICLE; COMPLEX REGIONAL PAIN SYNDROME; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH CENTER; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVE COMPRESSION; NEURALGIA; NEUROPATHIC PAIN; RADICULOPATHY; SPAIN;

EID: 35148893198     PISSN: 11348046     EISSN: 11348046     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. The Pain in Europe: a report. En URL: http://www.painineurope.com. Accedido el 26 de abril de 2005.
2. G.M. Bashford, Illawarra Pain Management Service, Port Kembla Hospital, Warrawong, N.S.W. The use of anticonvulsivants for neuropathic pain. Aust Prescr 1999; 22: 140-141
3. T.S. Jensen, H. Gottrup, S.H. Sindrup and F.W. Bach, The clinical picture of neuropathic pain. Eur J Pharmacol, 2001; 429: 1-11.
4. P. Hansson, Neuropathic pain: clinical characteristics and diagnostic workup. Eur J Pain, 2002; 6: 47-50.
5. C.J. Woolf and R.J. Mannion, Neuropathic pain aethiology, symptoms, mechanisms and management. Lancet, 1999; 353: 1959-1964.
6. R.H. Dworkin, M. Backonja, M.C. Rowbotham, R.R. Allen, C.R. Argoff, G.J. Bennett, M.C. Bushnell, J.T. Farrar, B.S. Galer, J.A. Haythornthwaite, D.J. Hewitt, J.D. Loeser, M.B. Max, M. Saltarelli, K.E. Schmader, C. Stein, D. Thompson, D.C. Turk, M.S. Wallace, L.R. Watkins and S.M. Weinstein, Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol, 2003; 60: 1524-1534.
7. F. Boureau, J.F. Doubrere and M. Luu, Study of verbal description in neuropathic pain. Pain 1990; 42: 145-152.
8. E.A. Masson, L. Hunt, J.M. Gem and J.M. Boulton, A novel approach to the diagnosis and assessment of symptomatic diabetic neuropathy. Pain, 1989; 38: 25-28.
9. S.J. Krause and M. Backonja, Development of a neuropathic pain questionnaire. Clin J Pain, 2003; 19: 306-314.
10. Fields HL, Martin JB: Pain: pathophysiology and management, in Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, Hauser SL, Longo DL (eds.): Harrison's Principles of Internal Medicine (14th edition). New York, NY, McGraw-Hill, 1998, pp. 55-58
11. H. Merskey and N. Bogduk, Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms (2nd edition). In: IASP Press, Seattle, WA (1994), pp. 212-213.
12. M. Backonja, A. Beydoun, K.R. Edwards, S.L. Schwartz, V. Fonseca, M. Hes, L. LaMoreaux and E. Garofalo, Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA, 1998; 280: 1831-1936.
13. R.H. Dworkin, An overview of neuropathic pain: syndromes, symptoms, signs, and several mechanisms. Clin J Pain, 2002; 18: 343-349.
14. J.A. Haythornthwaite and L.M. Benrud-Larson, Psychological aspects of neuropathic pain. Clin J Pain, 2000; 16: S101-S105.
15. National Institute of Neurological Disorders and Stroke. Peripheral Neuropathy Information Page. Disponible en: http://www.ninds.nih.gov/ health_and_medical /disorders/peripheralneuropathy_doc.htm. Accedido el 8 de Julio, 2005.
16. M. Rowbotham, N. Harden, B. Stacey, P. Bernstein and L. Magnus-Miller, Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA, 1998; 280: 1837-1842.
17. D.K. Weiner and J.T. Hanlon, Pain in nursing home residents: management strategies. Drugs Aging, 2001; 18: 13-29.
18. Zieglgansberger W, Berthele A, Tolle TR. Understanding neuropathic pain. CNS Spectr. 2005 Apr; 10 (4): 285-297.
19. Gisbert R, Brosa M. Base de datos de costes sanitarios. Soikos, Centre d'estudis en Economia de la Salut i de la Politica Social SL. Barcelona 2004.
20. Catálogo Oficial de Especialidades Farmacéuticas del Consejo General de Colegios Oficiales de Farmacéuticos de España. 2004.
21. Meyer-Rosberg K, Kvarnstrom A, Kinnman E, Gordh T, Nordfors LO, Kristofferson A. Peripheral neuropathic pain - a multidimensional burden for patients. Eur J Pain. 2001; 5 (4): 379-389.
22. K Vazquez. En Portada. El dolor: un asunto tan serio para el médico como para el paciente. Revista española de Economía de la Salud, 2003; 2 (5): 242-244.
23. Gálvez R, Ribera MV, Rejas J, Masramon X, Ruiz M. Neuropathic Pain (NeP) impact on patient mental functioning, symptom levels of anxiety and depression, and sleep disturbance: results from the DONEGA study. Value in Health 2004; 7 (6): 794.
24. Smith KJ, Roberts MS, Antiviral therapies for herpes zoster infections. Are they economically justifiable? Pharmacoeconomics 2000; 18 (2): 95-104.
25. Berger A, Dukes EM, Oster G. Clinical characteristics and economic costs of patients with painful neuropathic disorders. J Pain 2004; 5 (3): 143-149.